参考文献
[1]Hoppe-Seyler K,Bossler F,Braun J A,et al.The HPV E6/E7 oncogenes:key factors for viral carcinogenesis and therapeutic targets[J].Trends Microbiol,2018,26(2):158-168.
[2]Estevao D,Costa N R,Gil da Costa RM,et al.Hallmarks of HPV carcinogenesis:The role of E6,E7 and E5 oncoproteins in cellular malignancy[J].Biochim Biophys Acta Gene Regul Mech,2019,1862(2):153-162.
[3]de Martel C,Plummer M,Vignat J,et al.Worldwide burden of cancer attributable to HPV by site,country and HPV type[J].International Journal of Cancer,2017,141(4):664-670.
[4]Munoz N,Bosch FX,de Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527.
[5]Stratton KL,Culkin DJ.A Contemporary Review of HPV and Penile Cancer[J].Oncology(Williston Park),2016,30(3):245-249.
[6]Graham SV.The human papillomavirus replication cycle,and its links to cancer progression:a comprehensive review[J].Clin Sci(Lond),2017,131(17):2201-2221.
[7]Doorbar J,Egawa N,Griffin H,et al.Human papillomavirus molecular biology and disease association[J].Rev Med Virol,2015,25(Suppl 1):2-23.
[8]Hu Z,Zhu D,Wang W,et al.Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism[J].Nat Genet,2015,47(2):158-163.
[9]Oyervides-Munoz MA,Perez-Maya AA,Rodriguez-Gutierrez HF,et al.Understanding the HPV integration and its progression to cervical cancer[J].Infect Genet Evol,2018,61:134-144.
[10]Shukla S,Mahata S,Shishodia G,et al.Physical state© number of high risk human papillomavirus type 16 DNA in progression of cervical cancer[J].Indian J Med Res,2014,139(4):531-543.
[11]Vonsky M,Shabaeva M,Runov A,et al.Carcinogenesis Associated with human papillomavirus Infection.Mechanisms and Potential for Immunotherapy[J].Biochemistry(Mosc),2019,84(7):782-799.
[12]Chaiwongkot A,Vinokurova S,Pientong C,et al.Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions[J].Int J Cancer,2013,132(9):2087-2094.
[13]Doorbar J.The E4 protein;structure,function and patterns of expression[J].Virology,2013,445(1-2):80-98.
[14]Liao S,Deng D,Zhang W,et al.Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation,migration and invasion in vitro and accelerates tumor growth in vivo[J].Oncol Rep,2013,29(1):95-102.
[15]Veldman T,Horikawa I,Barrett JC,et al.Transcriptional activation of the telomerase h TERT gene by human papillomavirus type 16 E6 oncoprotein[J].J Virol,2001,75(9):4467-4472.
[16]Veldman T,Liu X,Yuan H,et al.Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter[J].Proc Natl Acad Sci,2003,100(14):8211-8216.
[17]Sekaric P,Cherry JJ,Androphy EJ.Binding of human papillomavirus type 16 E6 to E6AP is not required for activation of h TERT[J].J Virol,2008,82(1):71-76.(https://www.daowen.com)
[18]Howie HL,Katzenellenbogen RA,Galloway DA.Papillomavirus E6 proteins[J].Virology,2009,384(2),324-334.
[19]Moody CA,Laimins LA.Human papillomavirus oncoproteins:pathways to transformation[J].Nat Rev Cancer,2010,10(8):550-560.
[20]Talora C,Sgroi DC,Crum CP,et al.Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation[J].Genes Dev,2002,16(17):2252-2263.
[21]Yugawa T,Handa K,Narisawa-Saito M,et al.Regulation of Notch1 gene expression by p53 in epithelial cells[J].Mol Cell Biol,2007,27(10):3732-3742.
[22]Boyer SN,Wazer DE,Band V.E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway[J].Cancer Res,1996,56(20):4620-4624.
[23]Davies R,Hicks R,Crook T,et al.Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation[J].J Virol,1993,67(5):2521-2528.
[24]Morris EJ,Dyson NJ.Retinoblastoma protein partners[J].Adv Cancer Res,2001,82:1-54.
[25]Kero K,Rautava J.HPV Infections in Heterosexual Couples:Mechanisms and Covariates of Virus Transmission[J].Acta Cytol,2019,63(2):143-147.
[26]Tseng CJ,Liang CC,Soong YK,et al.Perinatal transmission of human papillomavirus in infants:relationship between infection rate and mode of delivery[J].Obstet Gynecol,1998,91(1):92-96.
[27]Zhao FH,Lewkowitz AK,Hu SY,et al.Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China:a pooled analysis of 17 population-based studies[J].Int J Cancer,2012,131(12):2929-2938.
[28]Kaderli R,Schnuriger B,Brugger LE.The impact of smoking on HPV infection and the development of anogenital warts[J].Int J Colorectal Dis,2014,29(8):899-908.
[29]Ramachandran B.Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis[J].Endocr Relat Cancer,2017,24(4):99-108.
[30]Dreyer G.Clinical implications of the interaction between HPV and HIV infections[J].Best Pract Res Clin Obstet Gynaecol,2018,47:95-106.
[31]Chao XP,Sun TT,Wang S,et al.Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection[J].Int J Gynecol Cancer,2019,29(1):28-34.
[32]Dahoud W,Michael CW,Gokozan H,et al.Association of Bacterial Vaginosis and Human Papilloma Virus Infection With Cervical Squamous Intraepithelial Lesions[J].Am J Clin Pathol,2019,152(2):185-189.
[33]吴绪峰.宫颈腺癌[M].武汉:湖北科学技术出版社,2020.